| SpectraBase Spectrum ID |
8SgjGmZXQ7i |
| Name |
N-Ethyl-3,4-methylenedioxyamphetamine PFO |
| Classification |
Methylenedioxyamphetamine designer drug derivative |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
603.089065821 u |
| Formula |
C20H16F15NO3 |
| InChI |
InChI=1S/C20H16F15NO3/c1-3-36(9(2)6-10-4-5-11-12(7-10)39-8-38-11)13(37)14(21,22)15(23,24)16(25,26)17(27,28)18(29,30)19(31,32)20(33,34)35/h4-5,7,9H,3,6,8H2,1-2H3 |
| InChIKey |
YQENUJRMKYPRMW-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
603.328 g/mol |
| Nominal Mass |
603 u |
| Quality |
887 |
| Retention Index |
4266 |
| SMILES |
C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(C(C(C(N(C(CC=1C=C2C(=CC1)OCO2)C)CC)=O)(F)F)(F)F)(F)F |
| SPLASH |
splash10-02ti-4900300000-d7a83dfc09f58fac56b4 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
MDE PFO
N-(1-(1,3-benzodioxol-5-yl)propan-2-yl)-N-ethyl-2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-\rpentadecafluorooctanamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_002690 |
